Dongwha Pharm.Co.,Ltd Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	10,505	13,305	25,656	72,317	34,347	60,480
Short-Term Investments	11,501	11,069	9,331	7,264	47,820	54,800
Trading Asset Securities	-	-	8,509	9,249	25,527	6,230
Cash & Short-Term Investments	22,005	24,374	43,497	88,830	107,695	121,510
Cash Growth	-44.51%	-43.96%	-51.03%	-17.52%	-11.37%	0.98%
Accounts Receivable	84,506	83,010	78,535	64,745	61,194	56,291
Other Receivables	15,541	7,989	21,979	9,622	5,491	4,803
Receivables	100,047	90,999	100,514	74,368	66,795	61,093
Inventory	99,821	97,867	89,329	70,697	46,784	36,244
Prepaid Expenses	1,750	2,050	2,474	1,912	843.38	403.11
Other Current Assets	2,204	2,325	1,992	1,893	5,411	948.43
Total Current Assets	225,828	217,615	237,806	237,700	227,527	220,199
Property, Plant & Equipment	209,602	210,056	219,546	188,330	151,153	142,851
Long-Term Investments	61,767	64,125	65,942	72,647	54,847	50,616
Goodwill	24,931	24,931	24,931	24,931	4,556	4,556
Other Intangible Assets	56,887	57,168	58,754	25,095	11,147	13,582
Long-Term Deferred Tax Assets	11,399	11,140	8,623	6,242	6,400	6,194
Other Long-Term Assets	57,509	57,133	4,034	3,575	5,507	9,807
Total Assets	647,922	642,168	619,635	558,520	461,136	447,804
Accounts Payable	42,206	42,709	38,865	31,412	22,232	17,119
Accrued Expenses	11,934	16,712	13,818	13,601	12,032	10,445
Short-Term Debt	95,126	92,665	31,330	14,670	2,500	4,500
Current Portion of Leases	4,342	4,214	5,864	4,547	2,120	1,918
Current Income Taxes Payable	4,604	3,164	4,160	2,224	2,932	4,481
Current Unearned Revenue	-	-	-	4.67	-	-
Other Current Liabilities	36,728	43,362	38,820	38,520	32,592	26,843
Total Current Liabilities	194,940	202,826	132,857	104,980	74,408	65,307
Long-Term Debt	15,134	14,349	44,500	16,128	477.13	3,460
Long-Term Leases	12,424	11,976	15,295	11,756	1,567	1,596
Long-Term Unearned Revenue	-	-	-	-	22.87	40.47
Pension & Post-Retirement Benefits	5,338	1,193	6,107	4,113	73.14	10,519
Long-Term Deferred Tax Liabilities	3,477	3,594	4,130	4,592	2,096	2,703
Other Long-Term Liabilities	6,961	6,791	13,916	13,014	2,664	2,892
Total Liabilities	238,274	240,728	216,805	154,582	81,309	86,517
Common Stock	27,931	27,931	27,931	27,931	27,931	27,931
Additional Paid-In Capital	18,565	18,520	17,757	17,757	27,545	27,545
Retained Earnings	308,560	300,355	292,330	292,251	274,356	252,712
Treasury Stock	-1,663	-1,663	-1,663	-1,663	-1,965	-1,965
Comprehensive Income & Other	34,613	34,383	37,016	35,503	36,534	40,712
Total Common Equity	388,007	379,527	373,371	371,780	364,400	346,935
Minority Interest	21,642	21,913	28,304	31,004	14,273	13,198
Shareholders' Equity	409,648	401,440	402,829	403,938	379,828	361,288
Total Liabilities & Equity	647,922	642,168	619,635	558,520	461,136	447,804
Total Debt	127,026	123,204	96,990	47,100	6,664	11,474
Net Cash (Debt)	-105,021	-98,830	-53,493	41,730	101,031	110,036
Net Cash Growth	-	-	-	-58.70%	-8.18%	5.15%
Net Cash Per Share	-4027.85	-3565.55	-1932.70	1507.27	3650.06	3981.90
Filing Date Shares Outstanding	27.75	27.72	27.72	27.72	27.68	27.68
Total Common Shares Outstanding	27.75	27.72	27.72	27.72	27.68	27.68
Working Capital	30,887	14,789	104,950	132,721	153,119	154,892
Book Value Per Share	13980.08	13692.47	13470.37	13412.96	13165.17	12534.17
Tangible Book Value	306,189	297,428	289,686	321,754	348,698	328,797
Tangible Book Value Per Share	11032.13	10730.53	10451.23	11608.15	12597.87	11878.87
Land	45,794	44,635	60,650	60,720	58,691	59,118
Buildings	174,383	173,337	122,036	116,422	110,623	111,571
Machinery	126,821	124,623	116,010	113,504	98,257	93,686
Construction In Progress	7,053	9,055	62,495	33,906	23,896	13,628